MHC tetramer detailed product information
HLA-A*24:02 CMV pp65 peptide
||100 µL (10 mg/ mL)
|Availability (in Japan)
||10 or more
（In Japan at 17:00, Apr 23, 2021 in JST）
||TS-0020-1C T-Select HLA-A*24:02 CMV pp65 Tetramer-QYDPVAALF-PE
TS-0020-2C T-Select HLA-A*24:02 CMV pp65 Tetramer-QYDPVAALF-APC
Tools:MHC tetramer Others
- Nishio-Nagai M et al. Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study. Int J Oncol. 51, 1471-1481 (2017)(PMID:29048671)
- The availability is based on the information in Japan at 17:00, Apr 23, 2021 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.
Copyright (C)2015 Medical ＆ Biological Laboratories Co., Ltd. All Rights Reserve